Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, Rhode Island.
Providence VA Medical Center, Providence, Rhode Island.
Alcohol Res. 2022 Feb 10;42(1):04. doi: 10.35946/arcr.v42.1.04. eCollection 2022.
The purpose of this review is to discuss the literature regarding the concurrent use (co-use) of alcohol and cannabis and competing hypotheses as to whether cannabis acts as a substitute for (i.e., replacing the effects of alcohol, resulting in decreased use) or a complement to (i.e., used to enhance the effects of alcohol, resulting in increased use) alcohol. The impact of cannabis use on alcohol-related outcomes has received increased attention in the wake of ongoing legalization of cannabis for both medical and recreational purposes. Evidence for both hypotheses exists in the literature across a broad range of data collection methods and samples and is carefully reviewed here. In addition, various mechanisms by which cannabis may act as an alcohol substitute or complement are explored in depth with the goal of better understanding equivocal findings.
This review includes articles that were identified from a search for studies on alcohol and cannabis co-use, with a specific focus on studies exploring complementary versus substitution aspects of co-use. Search terms were included in Google Scholar, PsycINFO, MEDLINE, and Web of Science. Eligible studies were those that measured alcohol and cannabis co-use in human samples in laboratory, survey, or ecological momentary assessment studies, or that directly referenced substitution or complementary patterns of use.
Search results returned 650 articles, with 95 meeting inclusion criteria.
Results of this review reveal compelling evidence for both substitution and complementary effects, suggesting nuanced yet significant distinctions across different populations examined in these studies. Several mechanisms for the impact of cannabis use on alcohol-related outcomes are identified, including patterns and context of co-use, timing and order of use, cannabinoid formulation, pharmacokinetic interactions, and user characteristics (including diagnostic status), all of which may influence substitution versus complementary effects. This review will inform future research studies examining this topic in both clinical and community samples and aid in the development of treatment and prevention efforts targeting those populations most vulnerable to negative consequences of co-use. Finally, this review highlights the need for additional research in more diverse samples and the use of mixed-methods designs to examine both pharmacological and contextual influences on co-use.
本综述旨在讨论有关同时使用(共用)酒精和大麻的文献,并探讨关于大麻是作为酒精的替代品(即,替代酒精的效果,导致使用量减少)还是补充剂(即,用于增强酒精的效果,导致使用量增加)的竞争假设。随着大麻在医疗和娱乐方面的使用合法化,大麻的使用对酒精相关结果的影响受到了越来越多的关注。本文综述了广泛的数据集和样本中这两种假设的证据,并进行了详细的审查。此外,还深入探讨了大麻作为酒精替代品或补充剂的各种作用机制,以期更好地理解相互矛盾的发现。
本综述包括从研究酒精和大麻共用来识别的文章,特别关注探索共用互补和替代方面的研究。搜索词包括在 Google Scholar、PsycINFO、MEDLINE 和 Web of Science 中。合格的研究是那些在实验室、调查或生态瞬间评估研究中测量人类样本中酒精和大麻共用量的研究,或者直接引用替代或补充使用模式的研究。
搜索结果返回 650 篇文章,其中 95 篇符合纳入标准。
本综述的结果揭示了替代和补充作用的有力证据,表明在这些研究中检查的不同人群中存在细微但显著的区别。确定了大麻使用对酒精相关结果的影响的几种机制,包括共用量的模式和背景、使用的时间和顺序、大麻素配方、药代动力学相互作用和用户特征(包括诊断状态),所有这些都可能影响替代或补充作用。本综述将为未来在临床和社区样本中研究这一主题的研究提供信息,并有助于针对最易受到共用量负面影响的人群制定治疗和预防措施。最后,本综述强调了在更多样化的样本中进行额外研究以及使用混合方法设计来研究共用量的药理学和环境影响的必要性。